Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trial
- Resource Type
- Article
- Source
- In
The Breast August 2017 34:18-23 - Subject
- Language
- ISSN
- 0960-9776